Evogene Ltd. (TLV:EVGN)
Israel · Delayed Price · Currency is ILS · Price in ILA 137.20
-18.30 (-11.77%)
Jul 14, 2026, 5:24 PM IDT
Evogene Market Cap
Evogene has a market cap or net worth of 16.19 million as of July 14, 2026. Its market cap has decreased by -54.32% in one year.
Market Cap
16.19M
Enterprise Value
14.65M
Revenue
5.82M
Ranking
n/a
PE Ratio
n/a
Stock Price
137.20
Market Cap Chart
Since October 15, 2007, Evogene's market cap has decreased from 113.15M to 16.19M, a decrease of -85.69%. That is a compound annual growth rate of -9.85%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2026 | 14.37M | -45.16% |
| Dec 31, 2025 | 26.20M | -44.67% |
| Dec 31, 2024 | 47.35M | -68.75% |
| Dec 31, 2023 | 151.55M | 64.52% |
| Dec 29, 2022 | 92.12M | -58.37% |
| Dec 30, 2021 | 221.26M | -59.72% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Geffen Residence & Renewal | 339.80M |
| Bonus BioGroup | 320.07M |
| Matricelf | 76.62M |
| Clal Biotechnology Industries | 42.51M |
| BioLineRx | 39.31M |
| BioLight Life Sciences | 33.48M |
| Can-Fite BioPharma | 21.46M |
| XTL Biopharmaceuticals | 19.66M |